These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10768625)

  • 1. Parkinson disease survival: a population-based study.
    Morgante L; Salemi G; Meneghini F; Di Rosa AE; Epifanio A; Grigoletto F; Ragonese P; Patti F; Reggio A; Di Perri R; Savettieri G
    Arch Neurol; 2000 Apr; 57(4):507-12. PubMed ID: 10768625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
    Hobson P; Meara J
    BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    JAMA Neurol; 2016 May; 73(5):535-41. PubMed ID: 26999262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.
    Uitti RJ; Ahlskog JE; Maraganore DM; Muenter MD; Atkinson EJ; Cha RH; O'Brien PC
    Neurology; 1993 Oct; 43(10):1918-26. PubMed ID: 8413948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan.
    Chen RC; Chang SF; Su CL; Chen TH; Yen MF; Wu HM; Chen ZY; Liou HH
    Neurology; 2001 Nov; 57(9):1679-86. PubMed ID: 11706111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
    Marras C; McDermott MP; Rochon PA; Tanner CM; Naglie G; Rudolph A; Lang AE;
    Neurology; 2005 Jan; 64(1):87-93. PubMed ID: 15642909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality associated with early and late levodopa therapy initiation in Parkinson's disease.
    Scigliano G; Musicco M; Soliveri P; Piccolo I; Girotti F; Giovannini P; Caraceni T
    Neurology; 1990 Feb; 40(2):265-9. PubMed ID: 2300246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of patients with idiopathic Parkinson's disease.
    Roos RA; Jongen JC; van der Velde EA
    Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
    Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
    Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up.
    Fall PA; Saleh A; Fredrickson M; Olsson JE; Granérus AK
    Mov Disord; 2003 Nov; 18(11):1312-6. PubMed ID: 14639673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?
    Ben-Shlomo Y; Marmot MG
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):293-9. PubMed ID: 7897409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of Parkinson's disease: a population-based study.
    D'Amelio M; Ragonese P; Morgante L; Reggio A; Callari G; Salemi G; Savettieri G
    J Neurol; 2006 Jan; 253(1):33-7. PubMed ID: 16021349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and cause of death in South Korean patients with Parkinson's disease: a longitudinal follow-up study using a national sample cohort.
    Choi HG; Lim JS; Lee YK; Sim S; Kim M
    BMJ Open; 2019 Sep; 9(9):e029776. PubMed ID: 31530603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
    Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
    Neurology; 2008 Apr; 70(16 Pt 2):1423-30. PubMed ID: 18413567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the basic and clinical aspects of Parkinson's disease].
    Mizuno Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):741-50. PubMed ID: 15651281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia and survival in Parkinson disease: a 12-year population study.
    Buter TC; van den Hout A; Matthews FE; Larsen JP; Brayne C; Aarsland D
    Neurology; 2008 Mar; 70(13):1017-22. PubMed ID: 18362281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy in Parkinson disease: prevalence and determinants.
    Rajabally YA; Martey J
    Neurology; 2011 Nov; 77(22):1947-50. PubMed ID: 22049200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of survival in patients with Parkinson disease.
    Willis AW; Schootman M; Kung N; Evanoff BA; Perlmutter JS; Racette BA
    Arch Neurol; 2012 May; 69(5):601-7. PubMed ID: 22213411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.